Hydroxamic acid: a potential human teratogen that could be recommended to treat ureaplasma.
Hydroxamic acid has been shown in experimental animals to be teratogenic. It can be used to treat chronic cervicitis; extreme caution is recommended to avoid exposure to this potential human teratogen.
Holmes
L B
LB
Department of Newborn Medicine, Brigham and Women's Hospital, Boston, Massachusetts 02115, USA.
D000014:Abnormalities, Drug-Induced; D000328:Adult; D000890:Anti-Infective Agents / Q000009:adverse effects* / Q000627:therapeutic use; D005260:Female; D006801:Humans; D006877:Hydroxamic Acids / Q000009:adverse effects* / Q000627:therapeutic use; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy*; D011261:Pregnancy Trimester, First; D016869:Ureaplasma Infections / Q000188:drug therapy*
D000890:Anti-Infective Agents; D006877:Hydroxamic Acids